Dr Vivek Khetpal, MD | |
2701 W. University Blvd, Durant, OK 74701-2997 | |
(580) 931-0500 | |
(580) 920-8027 |
Full Name | Dr Vivek Khetpal |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 36 Years |
Location | 2701 W. University Blvd, Durant, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154394823 | NPI | - | NPPES |
110159828 | Other | OK | MDC RR |
100225820A | Medicaid | OK |
Facility Name | Location | Facility Type |
---|---|---|
Mays Housecall Home Health Of Durant | Durant, OK | Home health agency |
Always Better Care Home Health | Durant, OK | Home health agency |
Complete Home Health Of Tishomingo Llc | Tishomingo, OK | Home health agency |
Genesis Healthcare,llc | Durant, OK | Home health agency |
Victory Home Health, Llc | Tishomingo, OK | Home health agency |
Alliancehealth Durant | Durant, OK | Hospital |
Choctaw Memorial Hospital | Hugo, OK | Hospital |
Atoka County Medical Center | Atoka, OK | Hospital |
Integris Marshall County Medical Center | Madill, OK | Hospital |
Choctaw Nation Health Services Authority | Talihina, OK | Hospital |
Calera Manor, Llc | Calera, OK | Nursing home |
Oakridge Nursing Center | Durant, OK | Nursing home |
The King's Daughters & Sons Nursing Home | Durant, OK | Nursing home |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Heart And Medical Center Inc | 7618953746 | 4 |
News Archive
Omeros Corporation today announced that the European Commission (EC) has granted marketing authorization for Omidria (phenylephrine and ketorolac injection) 1% / 0.3% in the European Union (EU) for use in cataract surgery and lens replacement procedures to maintain mydriasis (pupil dilation), prevent miosis (pupil constriction), and to reduce postoperative eye pain.
Robert Hunter Jr., M.D., Ph.D., Distinguished Chair in Molecular Pathology and chair of the Department of Pathology and Laboratory Medicine at The University of Texas Health Science Center at Houston Medical School, has received two prestigious awards.
People are much more likely to take preventive medicines if they're combined in one pill, an international study has found. The findings are published today in the Journal of the American Medical Association.
The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).
› Verified 8 days ago
Entity Name | Durant Hma Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770522906 PECOS PAC ID: 4981507472 Enrollment ID: O20040130001076 |
News Archive
Omeros Corporation today announced that the European Commission (EC) has granted marketing authorization for Omidria (phenylephrine and ketorolac injection) 1% / 0.3% in the European Union (EU) for use in cataract surgery and lens replacement procedures to maintain mydriasis (pupil dilation), prevent miosis (pupil constriction), and to reduce postoperative eye pain.
Robert Hunter Jr., M.D., Ph.D., Distinguished Chair in Molecular Pathology and chair of the Department of Pathology and Laboratory Medicine at The University of Texas Health Science Center at Houston Medical School, has received two prestigious awards.
People are much more likely to take preventive medicines if they're combined in one pill, an international study has found. The findings are published today in the Journal of the American Medical Association.
The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).
› Verified 8 days ago
Entity Name | Heart And Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1891773727 PECOS PAC ID: 7618953746 Enrollment ID: O20040628001530 |
News Archive
Omeros Corporation today announced that the European Commission (EC) has granted marketing authorization for Omidria (phenylephrine and ketorolac injection) 1% / 0.3% in the European Union (EU) for use in cataract surgery and lens replacement procedures to maintain mydriasis (pupil dilation), prevent miosis (pupil constriction), and to reduce postoperative eye pain.
Robert Hunter Jr., M.D., Ph.D., Distinguished Chair in Molecular Pathology and chair of the Department of Pathology and Laboratory Medicine at The University of Texas Health Science Center at Houston Medical School, has received two prestigious awards.
People are much more likely to take preventive medicines if they're combined in one pill, an international study has found. The findings are published today in the Journal of the American Medical Association.
The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Vivek Khetpal, MD 2701 W. University Blvd, Durant, OK 74701-2997 Ph: (580) 931-0500 | Dr Vivek Khetpal, MD 2701 W. University Blvd, Durant, OK 74701-2997 Ph: (580) 931-0500 |
News Archive
Omeros Corporation today announced that the European Commission (EC) has granted marketing authorization for Omidria (phenylephrine and ketorolac injection) 1% / 0.3% in the European Union (EU) for use in cataract surgery and lens replacement procedures to maintain mydriasis (pupil dilation), prevent miosis (pupil constriction), and to reduce postoperative eye pain.
Robert Hunter Jr., M.D., Ph.D., Distinguished Chair in Molecular Pathology and chair of the Department of Pathology and Laboratory Medicine at The University of Texas Health Science Center at Houston Medical School, has received two prestigious awards.
People are much more likely to take preventive medicines if they're combined in one pill, an international study has found. The findings are published today in the Journal of the American Medical Association.
The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).
› Verified 8 days ago
Saurabh Patel, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1801 Chukka Hina, Durant, OK 74701 Phone: 580-920-2100 | |
Nirmal Jot Kaur, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 Bryan Dr Ste 206, Durant, OK 74701 Phone: 580-931-2047 | |
Imran Plumb, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 Bryan Dr, Suite 208, Durant, OK 74701 Phone: 580-931-2256 | |
Satish Ramesh Bagdure, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 Bryan Dr Ste 208, Durant, OK 74701 Phone: 580-931-2256 | |
Deepak S. Jaiswal, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 702 Bryan Dr, Suite 100, Durant, OK 74701 Phone: 580-924-4704 Fax: 580-924-6001 | |
Dr. Kevin J Gordon, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1610 W University Blvd, Durant, OK 74701 Phone: 580-924-3400 Fax: 580-924-7732 |